Vivos Therapeutics: director Green Ralph Elias received 12,000 shares

What happened

• Green Ralph Elias, a director of Vivos Therapeutics, received a grant of 12,000 stock options on Sep 14, 2026. The grant is reported at an acquisition price of $0.00, total $0.00.
• One-half of the options (6,000) vested immediately, one-fourth (3,000) vests on Sep 30, 2026, and one-fourth (3,000) vests on Dec 31, 2026. The options are exercisable for a period of 10 years from the Sep 14, 2026 grant date. The filing also reflects that 667 options expired on Jun 19, 2025 and 1,200 options expired on Aug 5, 2026 unexercised.

Key details

• Transaction date and price: Sep 14, 2026; grant of 12,000 options at $0.00; total $0.00.
• Shares or securities owned after the transaction: the filing does not report the amount of securities beneficially owned following the transaction.
• Footnotes: footnote F1 describes the vesting schedule (6,000 immediate; 3,000 on Sep 30, 2026; 3,000 on Dec 31, 2026), 10-year exercisability from the grant date, and prior expirations of 667 and 1,200 options that expired unexercised.
• Filing date and timeliness: Form 4 filed on Oct 26, 2026 for a Sep 14, 2026 transaction (the filing date is more than two business days after the transaction).

Why it may matter

• This filing reports an option grant, not a market sale or purchase of common stock.
• The immediate vesting of half the grant creates an earliest possible exercise date for that tranche; the options remain exercisable for 10 years from Sep 14, 2026.
• The filing does not show why the insider traded or why the company acted.